encyclopedia of medical concepts
ψ
Phenylurea Compounds
More information
in Books
or on
Definition
:
DF: PHENYLUREA CPDS
Examples
Carbanilides
;
Celiprolol
;
Diflubenzuron
;
Diuron
;
Linuron
Other names
Phenylcarbamides; Compounds, Phenylurea
Substance
CAS Registry & name
Categories
Source
Drugs
*
PQ 401
0
*Aminoquinolines
*Phenylurea Compounds.
Mol Cancer Ther. 2006 Apr;5(4):1079-86.
1-
(4-
(2-
ethoxy-
4-
methyl-
1H-
pyrrol-
1-
yl)-
3-
hydroxy-
2,2-
dimethylchroman-
6-
yl)-
3-
phenylurea
0
*Phenylurea Compounds
Cromakalim/*analogs & derivatives.
Int J Oncol. 2011 Dec;39(6):1609-17.
BPR1K653
0
*Phenylurea Compounds
*Bicyclo Compounds, Heterocyclic.
PLoS One. 2011;6(8):e23485.
3-
(2,6-
dichloro-
3,5-
dimethoxyphenyl)-
1-
(6-
(4-
(4-
ethylpiperazin-
1-
yl)-
phenylamino)pyrimidin-
4-
yl)-
1-
methylurea
0
*Phenylurea Compounds
*Pyrimidines
Receptor, Fibroblast Growth Factor, Type 1/antagonists & inhibitors.
J Med Chem. 2011 Oct 27;54(20):7066-83.
SB 656933
0
*Phenylurea Compounds
*Sulfonamides
Receptors, Interleukin-8B/antagonists & inhibitors.
Br J Clin Pharmacol. 2011 Aug;72(2):282-93.
N-
(2-
(3-
(3,5-
bis(trifluoromethyl)phenyl)ureido)ethyl)glycyrrhetinamide
0
*Phenylurea Compounds
Glycyrrhetinic Acid/*analogs & derivatives.
J Med Chem. 2011 Oct 13;54(19):6501-13.
1-
(4-
(1-
(2,6-
difluorobenzyl)-
5-
((dimethylamino)methyl)-
3-
(6-
methoxypyridazin-
3-
yl)-
2,4-
dioxo-
1,2,3,4-
tetrahydrothieno(2,3-
d)pyrimidin-
6-
yl)phenyl)-
3-
methoxyurea
0
*Phenylurea Compounds
*Pyrimidinones
Receptors, LHRH/antagonists & inhibitors.
J Med Chem 2011 Jul 28;54(14):4998-5012
1-
(1-
methanesulfonylpiperidin-
4-
yl)-
3-
(4-
trifluoromethoxyphenyl)urea
0
*Phenylurea Compounds
*Piperidines
Epoxide Hydrolases/antagonists & inhibitors.
J Cardiovasc Pharmacol 2011 Mar;57(3):273-81
1-
(1-
(2-
amino-
pyridin-
4-
ylmethyl)-
1H-
indol-
4-
yl)-
3-
(5-
bromo-
2-
methoxyphenyl)urea
0
*Indoles
*Phenylurea Compounds
Receptor, EphB4/antagonists & inhibitors.
Biomed Chromatogr 2011 Jul;25(7):794-800
3,4-
dichlorophenylurea
0
*Phenylurea Compounds.
J Hazard Mater. 2011 Jun 15;190(1-3):930-7
XZH-
5 compound
0
*Phenylurea Compounds
Histidine/*analogs & derivatives.
Apoptosis 2011 May;16(5):502-10
4-
(4-
(((4-
chloro-
3-
(trifluoromethyl)phenyl)carbamoyl)amino)-
3-
fluorophenoxy)-
n-
methylpyridine-
2-
carboxamide
0
*Phenylurea Compounds
*Pyridines.
Int J Cancer 2011 Jul 1;129(1):245-55
1-
(6-
((2-
(dimethylamino)ethyl)(methyl)amino)-
1,3-
dimethyl-
1H-
pyrazolo(3,4-
b)pyridine-
5-
carbonyl)-
3-
(3-
isopropoxyphenyl)urea
0
*Phenylurea Compounds
*Bicyclo Compounds, Heterocyclic.
J Med Chem 2011 Mar 24;54(6):1667-81
(5-
hydroxycarbamoyl-
5-
(3-
(1-
hydroxycarbamoyl-
3-
methyl-
butyl)ureido)pentyl)carbamic acid benzyl ester
0
*Phenylurea Compounds
Lysine/*analogs & derivatives.
Bioorg Med Chem. 2011 Jan 15;19(2):900-6
1-
(1-
nicotinoylpiperidin-
4-
yl)-
3-
(4-
(trifluoromethoxy)phenyl)urea
0
Niacinamide/*analogs & derivatives
Phenylurea Compounds
Epoxide Hydrolases/antagonists & inhibitors.
Eur J Pharmacol 2011 Mar 1;654(1):68-74
DP 802
0
*Phenylurea Compounds
*Pyrazoles
p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors.
Bioorg Med Chem Lett 2010 Oct 1;20(19):5793-8
H128 compound
0
*Biphenyl Compounds
*Phenylurea Compounds
Diacylglycerol O-Acyltransferase/antagonists & inhibitors.
Acta Pharmacol Sin 2010 Nov;31(11):1470-7
1-
(2-
fluoro-
4-
((5-
methyl-
5H-
pyrrolo(3,2-
d)pyrimidin-
4-
yl)oxy)phenyl)-
3-
(3-
(trifluoromethyl)phenyl)urea
0
*Phenylurea Compounds
*Bicyclo Compounds, Heterocyclic
Vascular Endothelial Growth Factor Receptor-2/antagonists & inhibitors.
Bioorg Med Chem 2010 Oct 15;18(20):7260-73
1-
(2-
chloro-
4-
((5-
methyl-
5H-
pyrrolo(3,2-
d)pyrimidin-
4-
yl)oxy)phenyl)-
3-
(4-
((4-
methylpiperazin-
1-
yl)methyl)-
3-
(trifluoromethyl)phenyl)urea
0
*Phenylurea Compounds
*Bicyclo Compounds, Heterocyclic
Vascular Endothelial Growth Factor Receptor-2/antagonists & inhibitors
Receptor, Fibroblast Growth Factor, Type 1/antagonists & inhibitors.
Bioorg Med Chem 2010 Oct 15;18(20):7150-63
GDP 366
0
*Phenylurea Compounds
*Bicyclo Compounds, Heterocyclic.
Cancer Biol Ther 2010 Apr;9(8):640-50
tivozanib
0
*Phenylurea Compounds
*Quinolines
Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors.
IDrugs 2010 Sep;13(9):636-45
1-
(2-
(2-
(6-
aminohexylamino)ethoxy)-
5-
bromophenyl)-
3-
(2-
chlorophenyl)urea
0
*Phenylurea Compounds
Alzheimer Disease/drug therapy.
Bioorg Med Chem. 2010 Aug 1;18(15):5610-5
1-
(2-
hydroxy-
1-
phenylethyl)-
3-
(4-
(pyridin-
4-
yl)phenyl)urea
0
*Phenylurea Compounds
*Pyridines
rho-Associated Kinases/antagonists & inhibitors.
J Pharmacol Exp Ther 2010 Sep 1;334(3):955-63
ABT 116
0
*Indazoles
*Phenylurea Compounds
TRPV Cation Channels.
Bioorg Med Chem Lett 2010 Jun 1;20(11):3291-4
PKI 402
0
*Phenylurea Compounds
*Pyrimidines
Phosphatidylinositol 3-Kinases/antagonists & inhibitors.
Mol Cancer Ther 2010 Apr;9(4):976-84
1-
(2-
bromophenyl)-
3-
(7-
cyano-
3H-
benzotriazol-
4-
yl)urea
0
*Triazoles
*Phenylurea Compounds
Receptors, Interleukin-8B.
Br J Pharmacol 2009 Sep;158(1):328-38
N-
(2-
(dimethylamino)ethyl)-
N-
methyl-
4-
(((4-
(4-
morpholin-
4-
yl-
7-
(2,2,2-
trifluoroethyl)-
7H-
pyrrolo(2,3-
d)pyrimidin-
2-
yl)phenyl)carbamoyl)amino)benzamide
0
*Benzamides
*Phenylurea Compounds
Phosphatidylinositol 3-Kinases/antagonists & inhibitors.
J Med Chem 2010 Apr 22;53(8):3169-82
N6-
(((4-
(4-
(acetylamino)benzyl)phenyl)amino)carbonyl)lysine
0
*Phenylurea Compounds
Lysine/*analogs & derivatives.
Chem Res Toxicol 2009 Dec;22(12):1975-83
N6-
(((4-
(4-
aminobenzyl)phenyl)amino)carbonyl)lysine
0
*Phenylurea Compounds
Lysine/*analogs & derivatives.
Chem Res Toxicol 2009 Dec;22(12):1975-83
WYE 125132
0
*Phenylurea Compounds
*Pyrazoles.
Cancer Res 2010 Jan 15;70(2):621-31
nelotanserin
0
*Pyrazoles
*Phenylurea Compounds.
J Pharmacol Exp Ther 2010 Jan;332(1):281-90
1-
(4-
(6-
amino-